Kane Biotech Stock Market Value
| KNBIF Stock | USD 0.03 0 5.52% |
| Symbol | Kane |
Kane Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kane Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kane Biotech.
| 11/22/2025 |
| 02/20/2026 |
If you would invest 0.00 in Kane Biotech on November 22, 2025 and sell it all today you would earn a total of 0.00 from holding Kane Biotech or generate 0.0% return on investment in Kane Biotech over 90 days. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies ... More
Kane Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kane Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kane Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.18 | |||
| Information Ratio | 0.021 | |||
| Maximum Drawdown | 31.6 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.06 |
Kane Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kane Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kane Biotech's standard deviation. In reality, there are many statistical measures that can use Kane Biotech historical prices to predict the future Kane Biotech's volatility.| Risk Adjusted Performance | 0.0348 | |||
| Jensen Alpha | 0.0891 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0121 | |||
| Treynor Ratio | 0.129 |
Kane Biotech February 20, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0348 | |||
| Market Risk Adjusted Performance | 0.139 | |||
| Mean Deviation | 2.07 | |||
| Semi Deviation | 3.04 | |||
| Downside Deviation | 8.18 | |||
| Coefficient Of Variation | 2896.24 | |||
| Standard Deviation | 4.7 | |||
| Variance | 22.08 | |||
| Information Ratio | 0.021 | |||
| Jensen Alpha | 0.0891 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0121 | |||
| Treynor Ratio | 0.129 | |||
| Maximum Drawdown | 31.6 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.06 | |||
| Downside Variance | 66.88 | |||
| Semi Variance | 9.22 | |||
| Expected Short fall | (8.70) | |||
| Skewness | 1.15 | |||
| Kurtosis | 8.33 |
Kane Biotech Backtested Returns
Kane Biotech appears to be out of control, given 3 months investment horizon. Kane Biotech has Sharpe Ratio of 0.0542, which conveys that the firm had a 0.0542 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Kane Biotech, which you can use to evaluate the volatility of the firm. Please exercise Kane Biotech's Downside Deviation of 8.18, mean deviation of 2.07, and Risk Adjusted Performance of 0.0348 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kane Biotech holds a performance score of 4. The company secures a Beta (Market Risk) of 1.18, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kane Biotech will likely underperform. Please check Kane Biotech's semi variance, day typical price, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Kane Biotech's current price movements will revert.
Auto-correlation | 0.54 |
Modest predictability
Kane Biotech has modest predictability. Overlapping area represents the amount of predictability between Kane Biotech time series from 22nd of November 2025 to 6th of January 2026 and 6th of January 2026 to 20th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kane Biotech price movement. The serial correlation of 0.54 indicates that about 54.0% of current Kane Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.54 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Kane Pink Sheet
Kane Biotech financial ratios help investors to determine whether Kane Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kane with respect to the benefits of owning Kane Biotech security.